Comparing ligand interactions with multiple receptors via serial docking

被引:22
作者
Fernandes, MX [1 ]
Kairys, V [1 ]
Gilson, MK [1 ]
机构
[1] Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA
来源
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES | 2004年 / 44卷 / 06期
关键词
D O I
10.1021/ci049803m
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Standard uses of ligand-receptor docking typically focus on the association of candidate ligands with a Single targeted receptor, but actual applications increasingly require comparisons across multiple receptors. This study demonstrates that comparative docking to multiple receptors can help to select homology models for virtual compound screening and to discover ligands that bind to one set of receptors but not to another, potentially similar, set. A serial docking algorithm is furthermore described that reduces the computational Costs Of Such calculations by testing compounds against a series of receptor structures and discarding a compound as soon as it fails to satisfy specified bind/no bind criteria for each receptor. The algorithm also realizes Substantial efficiencies by taking advantage of the fact that a ligand typically binds in similar conformations to similar receptors. Thus, once detailed docking has been used to fit a ligand into the first of a series of similar receptors, much less extensive calculations can be used for the remaining structures.
引用
收藏
页码:1961 / 1970
页数:10
相关论文
共 60 条
[21]   Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: Insights into the mechanisms of drug resistance [J].
Hong, L ;
Zhang, XJC ;
Hartsuck, JA ;
Tang, J .
PROTEIN SCIENCE, 2000, 9 (10) :1898-1904
[22]   Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding [J].
Hopfner, KP ;
Lang, A ;
Karcher, A ;
Sichler, K ;
Kopetzki, E ;
Brandstetter, H ;
Huber, R ;
Bode, W ;
Engh, RA .
STRUCTURE, 1999, 7 (08) :989-996
[23]   INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C(2) SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE [J].
HOSUR, MV ;
BHAT, TN ;
KEMPF, DJ ;
BALDWIN, ET ;
LIU, BS ;
GULNIK, S ;
WIDEBURG, NE ;
NORBECK, DW ;
APPELT, K ;
ERICKSON, JW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (03) :847-855
[24]   A novel modeling protocol for protein receptors guided by bound-ligand conformation [J].
Johnson, MA ;
Höög, C ;
Pinto, BM .
BIOCHEMISTRY, 2003, 42 (07) :1842-1853
[25]   Enhanced docking with the mining minima optimizer: Acceleration and side-chain flexibility [J].
Kairys, V ;
Gilson, MK .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2002, 23 (16) :1656-1670
[26]  
Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO
[27]  
2-5
[28]   Molecular docking to ensembles of protein structures [J].
Knegtel, RMA ;
Kuntz, ID ;
Oshiro, CM .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 266 (02) :424-440
[29]   Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [J].
Kurumbail, RG ;
Stevens, AM ;
Gierse, JK ;
McDonald, JJ ;
Stegeman, RA ;
Pak, JY ;
Gildehaus, D ;
Miyashiro, JM ;
Penning, TD ;
Seibert, K ;
Isakson, PC ;
Stallings, WC .
NATURE, 1996, 384 (6610) :644-648
[30]   RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS [J].
LAM, PYS ;
JADHAV, PK ;
EYERMANN, CJ ;
HODGE, CN ;
RU, Y ;
BACHELER, LT ;
MEEK, JL ;
OTTO, MJ ;
RAYNER, MM ;
WONG, YN ;
CHANG, CH ;
WEBER, PC ;
JACKSON, DA ;
SHARPE, TR ;
ERICKSONVIITANEN, S .
SCIENCE, 1994, 263 (5145) :380-384